NewGenIvf (NIVFW) Revenue (2024 - 2025)

NewGenIvf (NIVFW) posted quarterly Revenue of $1.4 million for Q4 2025, up 11.85% YoY from $1.3 million in Q4 2024, and up 11.1% sequentially from $1.3 million in Q3 2025.

NewGenIvf (NIVFW) Revenue (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Revenue across 2 years of filings, most recently posting $1.4 million for Q4 2025.

  • In Q4 2025, Revenue rose 11.85% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $4.7 million, down 13.01% from the prior year.
  • Revenue grew to $1.4 million in Q4 2025, from $1.3 million in the prior quarter.
  • Over the last five years, Revenue for NIVFW reached as high as $1.5 million in Q3 2024 and fell as low as $1.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 19.11 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 657.51 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 5.37 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 3.42 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 1.59 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 1.39 Bn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 4.50 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 1.42 Bn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -200.76 Mn
10 NewGenIvf - - 524,025.00 1.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.42 Mn
Sep 30, 2025 1.28 Mn
Dec 31, 2024 1.27 Mn
Sep 30, 2024 1.47 Mn